SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Ensuring value for money in health care: the role of health technology assessment in the European Union
14 references·11 citing·45 second hop
Ensuring value for money in health care: the role of health technology assessment in the European Union (2008)Ensuring value for money in health care: …Bias in published cost effectiveness studies: systematic review (2006)Bias in published cost effect…International comparison of the definition and the practical application of health technology assessment (2005)International comparison of t…Growth and Quality of the Cost–Utility Literature, 1976–2001 (2005)Growth and Quality of the Cos…End-user involvement in health technology assessment (HTA) development: A way to increase impact (2005)End-user involvement in healt…Defining the “Health Benefit Basket” in nine European countries (2005)Defining the “Health Benefit …National Institute for Clinical Excellence and its value judgments (2004)National Institute for Clinic…Health technology assessment in England and Wales (2004)Health technology assessment …Health technology assessment and its influence on health-care priority setting (2004)Health technology assessment …Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Does NICE have a cost‐effecti…Resource allocation, social values and the QALY: a review of the debate and empirical evidence (2002)Resource allocation, social v…BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS (2002)BEST PRACTICE IN UNDERTAKING …Is Technological Change In Medicine Worth It? (2001)Is Technological Change In Me…Health Economic Guidelines—Similarities, Differences and Some Implications (2001)Health Economic Guidelines—Si…Medical Care Costs: How Much Welfare Loss? (1992)Medical Care Costs: How Much …Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries (2021)Similarities and Differences …Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art (2019)Multi-criteria decision analy…Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients (2018)Health related quality of lif…How OECD health systems define the range of good and services to be financed collectively (2016)How OECD health systems defin…Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders (2014)Incremental cost per quality-…Using health technology assessment for informing coverage decisions in Thailand (2012)Using health technology asses…The Importance of Values in Shaping How Health Systems Governance and Management Can Support Universal Health Coverage (2012)The Importance of Values in S…Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions (2012)Commonalities and differences…Health Technology Funding Decision-Making Processes Around the World (2011)Health Technology Funding Dec…Responding to the challenge of financial sustainability in Estonia's health system (2010)Responding to the challenge o…Medical technology procurement in Europe: A cross-country comparison of current practice and policy (2010)Medical technology procuremen…Health Care Needs and Distributive Justice (1983)Cost-Value Analysis in Health Care (1999)The global challenge of health care rationing (2000)Exploring the social value of health‐care interventions: a stated preference discrete choice experiment (2008)Health Technology Assessment: Lessons Learned from Around the World—An Overview (2009)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold (2008)Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)The Existence of Publication Bias and Risk Factors for Its Occurrence (1990)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost-Effectiveness in Health and Medicine (1996)Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2 (2012)Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010 (2014)Corporate practices and health: a framework and mechanisms (2018)The Measurement of Observer Agreement for Categorical Data (1977)Methods for the Economic Evaluation of Health Care Programmes (2005)Trends in the Measurement of Health Utilities in Published Cost-Utility Analyses (2006)Costing and Perspective in Published Cost-Effectiveness Analysis (2009)Decision Analysis and Cost-Effectiveness Analysis (2009)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Qualitative research in health care: Assessing quality in qualitative research (2000)HTA 101 INTRODUCTION TO HEALTH TECHNOLOGY ASSESSMENT (2004)Patient-based health technology assessment: A vision of the future (2007)Bridging Health Technology Assessment (HTA) and Efficient Health Care Decision Making with Multicriteria Decision Analysis (MCDA) (2011)The Market for "Lemons": Quality Uncertainty and the Market Mechanism (1970)Equilibrium in Competitive Insurance Markets: An Essay on the Economics of Imperfect Information (1976)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare (2007)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)Quantifying the burden of disease: the technical basis for disability-adjusted life years. (1994)Intergenerational Equity: An Exploration of the ‘Fair Innings’ Argument (1997)Asymmetries of Poverty: Why Global Burden of Disease Valuations Underestimate the Burden of Neglected Tropical Diseases (2008)Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology (2014)Attributes and weights in health care priority setting: A systematic review of what counts and to what extent (2015)EuroQol: the current state of play (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)Delivering affordable cancer care in high-income countries (2011)Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Quality-Adjusted Life-Years Lack Quality in Pediatric Care: A Critical Review of Published Cost-Utility Studies in Child Health (2005)Using Value of Information Analysis to Prioritise Health Research (2006)Propuesta de guía para la evaluación económica aplicada a las tecnologías sanitarias (2009)The Aging Population and Its Impact on the Surgery Workforce (2003)Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States (2016)
this work references cited by second hop

References

  • 1992Medical Care Costs: How Much Welfare Loss?1,220 cited
  • 2001Is Technological Change In Medicine Worth It?904 cited
  • 2004National Institute for Clinical Excellence and its value judgments767 cited
  • 2004Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis710 cited
  • 2006Bias in published cost effectiveness studies: systematic review383 cited
  • 2001Health Economic Guidelines—Similarities, Differences and Some Implications322 cited
  • 2002BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS216 cited
  • 2002Resource allocation, social values and the QALY: a review of the debate and empirical evidence183 cited
  • 2005Growth and Quality of the Cost–Utility Literature, 1976–2001161 cited
  • 2004Health technology assessment and its influence on health-care priority setting149 cited
  • 2004Health technology assessment in England and Wales131 cited
  • 2005End-user involvement in health technology assessment (HTA) development: A way to increase impact125 cited
  • 2005International comparison of the definition and the practical application of health technology assessment124 cited
  • 2005Defining the “Health Benefit Basket” in nine European countries109 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

  • 2019Multi-criteria decision analysis for health technology assessment: addressing methodological challenges to improve the state of the art113 cited
  • 2010Medical technology procurement in Europe: A cross-country comparison of current practice and policy98 cited
  • 2021Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 Countries93 cited
  • 2012Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions93 cited
  • 2018Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients90 cited
  • 2011Health Technology Funding Decision-Making Processes Around the World84 cited
  • 2012Using health technology assessment for informing coverage decisions in Thailand79 cited
  • 2014Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders73 cited
  • 2012The Importance of Values in Shaping How Health Systems Governance and Management Can Support Universal Health Coverage26 cited
  • 2010Responding to the challenge of financial sustainability in Estonia's health system24 cited
  • 2016How OECD health systems define the range of good and services to be financed collectively24 cited